Aug. 29 at 5:48 PM
$BLGO Wanted to chase the financing angle which has lead to some fascinating stuff. In any case an explanation is needed as the ClearThink facility became effective, BioLargo has issued roughly 6.75 million shares for approximately
$767,000 while the stock has fallen from roughly the mid-
$0.16s to around
$0.10. So BioLargo raised less than
$1 million, while shareholders experienced something on the order of a
$20+ million reduction in market capitalization. Any thoughts on this? Obviously selling pressure due to BioLargo common stock is the main contributor, but additionally I think it’s related to an existing financing network that reorganized how it participates in BLGO and shifts the primary equity-line vehicle from the older structure into ClearThink Capital Partners. Was the August 20–21 large share turnover a major inventory-clearing event and BioLargo hasn’t issued another tranche? If so the supply environment today may be considerably healthier than it was two weeks ago.
